Skip to main content
. 2020 Jan 24;40(1):BSR20193309. doi: 10.1042/BSR20193309

Figure 1. LncRNA FGD5-AS1 was highly expressed in NSCLC tissues and cells, and promoted the proliferation of NSCLC cells.

Figure 1

(A) qRT-PCR assays were performed to investigate the expressions of FGD5-AS1 in NSCLC tumor tissues and non-tumor tissues. (B) The expressions of FGD5-AS1 were detected in cell lines (IMR-90, NCI-H1703, NCI-H1793 and NCI-H1869) by qRT-PCR assays. (C) The survival rate of high expression and low expression of FGD5-AS1 patient groups were contrasted by Pearson’s experiment. (D) qRT-PCR assays were conducted to detect the inference efficiency of FGD5-AS1 in two different NSCLC cell lines, NCI-H1703 and NCI-H1793. (E–G) CCK-8, colony formation and EdU assays were implemented to detect the relative cell proliferation ability in NSCLC cell lines (NCI-H1703 and NCI-H1793) by sh-FGD5-AS1#1, #2. (H) TUNEL was performed to appraise the apoptosis rate of two NSCLC cell lines (NCI-H1703 and NCI-H1793). **P<0.01 indicated that differences between groups were statistically significant.